SEARCH

SEARCH BY CITATION

References

  • Anderson S. M. and Brunzell D. H. (2012) Low dose nicotine and antagonism of β2 subunit containing nicotinic acetylcholine receptors have similar effects on affective behavior in mice. PLoS ONE 7, e48665.
  • Aubin H. J., Farley A., Lycett D., Lahmek P. and Aveyard P. (2012) Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ 345, e4439.
  • Benwell M. E., Balfour D. J. and Anderson J. M. (1988) Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain. J. Neurochem. 50, 12431247.
  • Breese C. R., Marks M. J., Logel J., Adams C. E., Sullivan B., Collins A. C. and Leonard S. (1997) Effect of smoking history on [3H]nicotine binding in human postmortem brain. J. Pharmacol. Exp. Ther. 282, 713.
  • Caldarone B. J., Wang D., Paterson N. E. et al. (2011) Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380. Psychopharmacology 217, 199210.
  • Carbone A. L., Moroni M., Groot-Kormelink P. J. and Bermudez I. (2009) Pentameric concatenated (α4)2(β2)3 and (α4)3(β2)2 nicotinic acetylcholine receptors: subunit arrangement determines functional expression. Br. J. Pharmacol. 156, 970981.
  • Centers for Disease Control and Prevention (CDC) (2012) Preventing tobacco use among youth and young adults: a report of the surgeon general. U.S. Department of Health and Human Services.
  • Clarke P. B., Schwartz R. D., Paul S. M., Pert C. B. and Pert A. (1985) Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin. J. Neurosci. 5, 13071315.
  • Cosgrove K. P., Batis J., Bois F. et al. (2009) β2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Arch. Gen. Psychiatry 66, 666676.
  • Dani J. A. and Heinemann S. (1996) Molecular and cellular aspects of nicotine abuse. Neuron 16, 905908.
  • Dulawa S. C., Holick K. A., Gundersen B. and Hen R. (2004) Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29, 13211330.
  • File S. E., Kenny P. J. and Ouagazzal A. M. (1998) Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus. Behav. Neurosci. 112, 14231429.
  • Flores C. M., Rogers S. W., Pabreza L. A., Wolfe B. B. and Kellar K. J. (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol. Pharmacol. 41, 3137.
  • George O., Lloyd A., Carroll F. I., Damaj M. I. and Koob G. F. (2011) Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration. Psychopharmacology 213, 715722.
  • Gotti C., Moretti M., Meinerz N. M., Clementi F., Gaimarri A., Collins A. C. and Marks M. J. (2008) Partial deletion of the nicotinic cholinergic receptor α4 or β2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of α4 and β2 subunits. Mol. Pharmacol. 73, 17961807.
  • Gotti C., Clementi F., Fornari A., Gaimarri A., Guiducci S., Manfredi I., Moretti M., Pedrazzi P., Pucci L. and Zoli M. (2009) Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem. Pharmacol. 78, 703711.
  • Govind A. P., Vezina P. and Green W. N. (2009) Nicotine-induced up-regulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem. Pharmacol. 78, 756765.
  • Govind A. P., Walsh H. and Green W. N. (2012) Nicotine-induced up-regulation of native neuronal nicotinic receptors is caused by multiple mechanisms. J. Neurosci. 32, 22272238.
  • Grady S., Marks M. J., Wonnacott S. and Collins A. C. (1992) Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59, 848856.
  • Grady S. R., Marks M. J. and Collins A. C. (1994) Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes. J. Neurochem. 62, 13901398.
  • Grunberg N. E., Winders S. E. and Popp K. A. (1987) Sex differences in nicotine's effects on consummatory behavior and body weight in rats. Psychopharmacology 91, 221225.
  • Hogle J. M., Kaye J. T. and Curtin J. J. (2010) Nicotine withdrawal increases threat-induced anxiety but not fear: neuroadaptation in human addiction. Biol. Psychiatry 68, 719725.
  • Hulihan-Giblin B. A., Lumpkin M. D. and Kellar K. J. (1990) Acute effects of nicotine on prolactin release in the rat: agonist and antagonist effects of a single injection of nicotine. J. Pharmacol. Exp. Ther. 252, 1520.
  • Hussmann G. P., Turner J. R., Lomazzo E. et al. (2012) Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain. J. Pharmacol. Exp. Ther. 343, 441450.
  • Johnson J. E, Slade S., Wells C. et al. (2012) Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats. Psychopharmacology 222, 269276.
  • Kozikowski A. P., Eaton J. B., Bajjuri K. M. et al. (2009) Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression. ChemMedChem 4, 12791291.
  • Kuryatov A., Luo J., Cooper J. and Lindstrom J. (2005) Nicotine acts as a pharmacological chaperone to up-regulate human acetylcholine receptors. Mol. Pharmacol. 68, 18391851.
  • Lester R. A. and Dani J. A. (1995) Acetylcholine receptor desensitization induced by nicotine in rat medial habenula neurons. J. Neurophysiol. 74, 195206.
  • Levin E. D., Rezvani A. H., Xiao Y. et al. (2010) Sazetidine-A, a selective α4β2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats. J. Pharmacol. Exp. Ther. 332, 933939.
  • Lomazzo E., Hussmann G. P., Wolfe B. B., Yasuda R. P., Perry D. C. and Kellar K. J. (2011) Effects of chronic nicotine on heteromeric neuronal nicotinic receptors in rat primary cultured neurons. J. Neurochem. 119, 153164.
  • Mao D., Perry D. C., Yasuda R. P., Wolfe B. B. and Kellar K. J. (2008) The α4β2α5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo. J. Neurochem. 104, 446456.
  • Marks M. J., Burch J. B. and Collins A. C. (1983) Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J. Pharmacol. Exp. Ther. 226, 817825.
  • Marks M. J., Stitzel J. A. and Collins A. C. (1985) Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J. Pharmacol. Exp. Ther. 235, 619628.
  • Marks M. J., Pauly J. R., Gross S. D., Deneris E. S., Hermans-Borgmeyer I., Heinemann S. F. and Collins A. C. (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J. Neurosci. 12, 27652784.
  • Marks M. J., Grady S. R., Yang J. M., Lippiello P. M. and Collins A. C. (1994) Desensitization of nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes. J. Neurochem. 63, 21252135.
  • Marks M. J., McClure-Begley T. D., Whiteaker P., Salminen O., Brown R. W., Cooper J., Collins A. C. and Lindstrom J. M. (2011) Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain. J. Pharmacol. Exp. Ther. 337, 187200.
  • Maskos U., Molles B. E., Pons S. et al. (2005) Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436, 103107.
  • Mazzaferro S., Benallegue N., Carbone A., Gasparri F., Vijayan R., Biggin P. C., Moroni M. and Bermudez I. (2011) Additional Acetylcholine (ACh) Binding Site at α4/α4 interface of (α4β2) 2α4 nicotinic receptor influences agonist sensitivity. J. Biol. Chem. 286, 3104331054.
  • McGranahan T. M., Patzlaff N. E., Grady S. R., Heinemann S. F. and Booker T. K. (2011) α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief. J. Neurosci. 31, 1089110902.
  • Mineur Y. S., Abizaid A., Rao Y. et al. (2011) Nicotine decreases food intake through activation of POMC neurons. Science 332, 13301332.
  • Moretti M., Mugnaini M., Tessari M., Zoli M., Gaimarri A., Manfredi I., Pistillo F., Clementi F. and Gotti C. (2010) A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes. Mol. Pharmacol. 78, 287296.
  • Nashmi R., Deshpande P., McKinney S. et al. (2007) Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J. Neurosci. 27, 82028218.
  • Ortells M. O. and Barrantes G. E. (2010) Tobacco addiction: a biochemical model of nicotine dependence. Med. Hypotheses 74, 884894.
  • Patterson F., Jepson C., Strasser A. A., Loughead J., Perkins K. A., Gur R. C., Frey J. M., Siegel S. and Lerman C. (2009) Varenicline improves mood and cognition during smoking abstinence. Biol. Psychiatry 65, 144149.
  • Perry D. C., Dávila-García M. I., Stockmeier C. A. and Kellar K. J. (1999) Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J. Pharmacol. Exp. Ther. 289, 15451552.
  • Perry D. C., Xiao Y., Nguyen H. N., Musachio J. L., Dávila-García M. I. and Kellar K. J. (2002) Measuring nicotinic receptors with characteristics of α4β2, α3β2 and α3β4 subtypes in rat tissues by autoradiography. J. Neurochem. 82, 468481.
  • Picciotto M. R., Zoli M., Rimondini R., Léna C., Marubio L. M., Pich E. M., Fuxe K. and Changeux J. P. (1998) Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 391, 173177.
  • Picciotto M. R., Brunzell D. H. and Caldarone B. J. (2002) Effect of nicotine and nicotinic receptors on anxiety and depression. NeuroReport 13, 10971106.
  • Pidoplichko V. I., DeBiasi M., Williams J. T. and Dani J. A. (1997) Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390, 401404.
  • Piper M. E., Cook J. W., Schlam T. R., Jorenby D. E. and Baker T. B. (2011) Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. Addiction 106, 418427.
  • Pomerleau O. F., Pomerleau C. S., Mehringer A. M., Snedecor S. M., Ninowski R. and Sen A. (2005) Nicotine dependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain. Nicotine Tob. Res. 7, 91102.
  • Rapier C., Lunt G. G. and Wonnacott S. (1988) Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation. J. Neurochem. 50, 11231130.
  • Rezvani A. H., Slade S., Wells C. et al. (2010) Effects of sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats. Psychopharmacology 211, 161174.
  • Rezvani A. H, Cauley M., Xiao Y., Kellar K. J. and Levin E. D. (2013) Effects of chronic sazetidine-A, a selective α4β2 neuronal nicotinic acetylcholine receptors desensitizing agent on pharmacologically-induced impaired attention in rats. Psychopharmacology 226, 3543.
  • Rowell P. P. and Wonnacott S. (1990) Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes. J. Neurochem. 55, 21052110.
  • Sallette J., Bohler S., Benoit P., Soudant M., Pons S., Le Novère N., Changeux J. P. and Corringer P. J. (2004) An extracellular protein microdomain controls up-regulation of neuronal nicotinic acetylcholine receptors by nicotine. J. Biol. Chem. 279, 1876718775.
  • Sallette J., Pons S., Devillers-Thiery A., Soudant M., Prado de Carvalho L., Changeux J. P. and Corringer P. J. (2005) Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 46, 595607.
  • Schwartz R. D. and Kellar K. J. (1983) Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220, 214216.
  • Schwartz R. D. and Kellar K. J. (1985) In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J. Neurochem. 45, 427433.
  • Schwartz R. D., Lehmann J. and Kellar K. J. (1984) Presynaptic nicotinic cholinergic receptors labeled by [3H]acetylcholine on catecholamine and serotonin axons in brain. J. Neurochem. 42, 14951498.
  • Sharp B. M. and Beyer H. S. (1986) Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin. J. Pharmacol. Exp. Ther. 238, 486491.
  • Srinivasan R., Pantoja R., Moss F. J., Mackey E. D., Son C. D., Miwa J. and Lester H. A. (2011) Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning. J. Gen. Physiol. 137, 5979.
  • Staley J. K., Krishnan-Sarin S., Cosgrove K. P. et al. (2006) Human tobacco smokers in early abstinence have higher levels of β2* nicotinic acetylcholine receptors than nonsmokers. J. Neurosci. 26, 87078714.
  • Tapper A. R., McKinney S. L., Nashmi R., Schwarz J., Deshpande P., Labarca C., Whiteaker P., Marks M. J., Collins A. C. and Lester H. A. (2004) Nicotine activation of α4* receptors: sufficient for reward, tolerance and sensitization. Science 306, 10291032.
  • Turner J. R., Castellano L. M. and Blendy J. A. (2010) Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior. J. Pharmacol. Exp. Ther. 334, 665672.
  • Turner J. R., Castellano L. M. and Blendy J. A. (2011) Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline. Nicotine Tob. Res. 13, 4146.
  • Vallejo Y. F., Buisson B., Bertrand D. and Green W. N. (2005) Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J. Neurosci. 25, 55635572.
  • Varani A. P., Moutinho L. M., Bettler B. and Balerio G. N. (2012) Acute behavioural responses to nicotine and nicotine withdrawal syndrome are modified in GABA(B1) knockout mice. Neuropharmacology 63, 863872.
  • Weinberger A. H., Desai R. A. and McKee S. A. (2010) Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disorders. Drug Alcohol Depend. 108, 712.
  • Wouda J. A., Riga D., De Vries W., Stegeman M., van Mourik Y., Schetters D., Schoffelmeer A. N., Pattij T. and De Vries T. J. (2011) Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control. Psychopharmacology 216, 267277.
  • Wüllner U., Gündisch D., Herzog H. et al. (2008) Smoking upregulates α4β2* nicotinic acetylcholine receptors in the human brain. Neurosci. Lett. 430, 3437.
  • Xiao Y., Fan H., Musachio J. L., Wei Z. L., Chellappan S. K., Kozikowski A. P. and Kellar K. J. (2006) Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic aceylcholine receptors without activating them. Mol. Pharmacol. 70, 14541460.
  • Zarrindast M. R., Tajik R., Ebrahimi-Ghiri M., Nasehi M. and Rezayof A. (2013) Role of the medial septum cholinoceptors in anxiogenic-like effects of nicotine. Physiol. Behav. 119, 103109.
  • Zoli M. and Picciotto M. R. (2012) Nicotinic regulation of energy homeostasis. Nicotine Tob. Res. 14, 12701290.
  • Zoli M., Moretti M., Zanardi A., McIntosh J. M., Clementi F. and Gotti C. (2002) Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J. Neurosci. 22, 87858789.
  • Zwart R., Carbone A. L., Moroni M. et al. (2008) Sazetidine A is a potent and selective agonist at native and recombinant α4β2 nicotinic acetylcholine receptors. Mol. Pharmacol. 73, 18381843.